U.S. Medical Writing Market Size & Outlook, 2025-2033
The medical writing market in the United States is expected to reach a projected revenue of US$ 3,250.6 million by 2033. A compound annual growth rate of 9.1% is expected of the United States medical writing market from 2025 to 2033.
PAREXEL, Indegene, FREYR Battery Inc, Cactus Inc Class A, Labcorp Drug Development, IQVIA Holdings Inc, Certara Inc Ordinary Shares
Other key industry trends
In terms of revenue, U.S. accounted for 32.2% of the global medical writing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. medical writing market is projected to lead the regional market in terms of revenue in 2033.
Canada is the fastest growing regional market in North America and is projected to reach USD 338.8 million by 2033.
Regulatory writing is one of the services provided in medical writing. It includes generating various clinical documents that describe the treatment lifecycle, ranging from reporting clinical trial data to preparing postapproval reports about the use of treatment in patients.
Medical writers are expected to meet regulatory requirements and adhere to guidelines, including International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines. High number of clinical studies being carried out increases the demand for medical writers and is expected to drive the U.S. medical writing market during the forecast period.
For instance, in February 2020, there were about 330,113 clinical studies registered on clinical trial databases, out of which 111,640 were registered in the U.S. There are professional organizations setup for medical writers. For instance, in the U.S., the American Medical Writers Association (AMWA) acts as a platform for editors, writers, and other communicators of medical information.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Writing Market Outlook will help companies and investors design strategic landscapes.
Clinical Writing was the largest segment with a revenue share of 43.67% in 2024.
Horizon Databook has segmented the U.S. medical writing market based on clinical writing, regulatory writing, scientific writing covering the revenue growth of each sub-segment from 2021 to 2033.
Regulatory writing is one of the services provided in medical writing. It includes generating various clinical documents that describe the treatment lifecycle, ranging from reporting clinical trial data to preparing postapproval reports about the use of treatment in patients.
Medical writers are expected to meet regulatory requirements and adhere to guidelines, including International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines. High number of clinical studies being carried out increases the demand for medical writers and is expected to drive the U.S. medical writing market during the forecast period.
For instance, in February 2020, there were about 330,113 clinical studies registered on clinical trial databases, out of which 111,640 were registered in the U.S. There are professional organizations setup for medical writers. For instance, in the U.S., the American Medical Writers Association (AMWA) acts as a platform for editors, writers, and other communicators of medical information.
U.S. Medical Writing Market Type Outlook (Revenue, USD Million , 2021-2033)
Clinical Writing
Regulatory Writing
Scientific Writing
Others
U.S. Medical Writing Market Application Outlook (Revenue, USD Million , 2021-2033)
Medical Journalism
Medical Education
Medico Marketing
Others
U.S. Medical Writing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Medical Device/Pharma & Biotech Companies
CROs & Others
Reasons to subscribe to Medical Writing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Writing Market Outlook databook
Our clientele includes a mix of Medical Writing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Medical Writing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Medical Writing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.